1.
Rodríguez Quintosa J, Ago CC, Sicras Mainar A, Villoro R, Pérez-Román I. Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain. Grhta [Internet]. 2022 Oct. 18 [cited 2024 Nov. 21];9(1):133-7. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2439